10 pending office actions • 7 clients
| Client (Assignee) | Pending OAs |
|---|---|
| The Board Of Trustees Of The Leland Stanford Junior University | 3 |
| Amylyx Pharmaceuticals, Inc. | 2 |
| Cybrexa 2, Inc. | 1 |
| Amylyx Pharmaceuticals, Inc. | 1 |
| Cybrexa 2, Inc. | 1 |
| Cybrexa 4, Inc. | 1 |
| Carnegie Mellon University | 1 |
| App # | Title | Client | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|---|
| 19358715 | Untitled | The Board Of Trustees Of The Leland Stanford Junior University | SABILA, MERCY HELLEN | 1654 | Non-Final OA | |
| 19353711 | Untitled | The Board Of Trustees Of The Leland Stanford Junior University | SABILA, MERCY HELLEN | 1654 | Non-Final OA | |
| 18443821 | METHODS AND COMPOSITIONS FOR TREATING AMYOTROPHIC LATERAL SCLEROSIS | Amylyx Pharmaceuticals, Inc. | HUYNH, PHUONG N | 1641 | Non-Final OA | Feb 16, 2024 |
| 18288650 | DOSING REGIMENS OF PEPTIDE CONJUGATES OF TOPOISOMERASE I INHIBITORS | Cybrexa 2, Inc. | MIKNIS, ZACHARY J | 1658 | Non-Final OA | Oct 27, 2023 |
| 18471413 | COMPOSITIONS OF EXENDIN-4 DERIVATIVES | Amylyx Pharmaceuticals, Inc. | HELLMAN, KRISTINA M | 1654 | Final Rejection | Sep 21, 2023 |
| 18356591 | OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF | Amylyx Pharmaceuticals, Inc. | BRETZ, COREY LANE | 1635 | Non-Final OA | Jul 21, 2023 |
| 18271121 | PROCESS FOR PREPARING A CONJUGATE LINKING MOIETY | Cybrexa 2, Inc. | MEAH, MOHAMMAD Y | 1652 | Non-Final OA | Jul 06, 2023 |
| 18339305 | Buffered Formulations Of Exendin (9-39) | The Board Of Trustees Of The Leland Stanford Junior University | LIEB, JEANETTE M | 1654 | Non-Final OA | Jun 22, 2023 |
| 18056117 | PEPTIDE CONJUGATES OF PEPTIDIC TUBULIN INHIBITORS AS THERAPEUTICS | Cybrexa 4, Inc. | REYNOLDS, FRED H | 1658 | Non-Final OA | Nov 16, 2022 |
| 16434869 | Fe-Ni Nanocomposite Alloys | Carnegie Mellon University | HILL, STEPHANI A | 1735 | Non-Final OA | Jun 07, 2019 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial